UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of β2 -adrenergic receptor gene Arg16Gly polymorphisms on response to long-acting β2-agonist in Chinese Han asthmatic patients

Multidisciplinary respiratory medicine, 2014-12, Vol.9

2014

Volltextzugriff (PDF)

Glucocorticoid induced TNFR-related protein (GITR) as marker of human regulatory T cells: expansion of the GITR(+)CD25⁻ cell subset in patients with systemic lupus erythematosus

Reumatismo, 2010-07, Vol.62 (3), p.195-201

2010

Volltextzugriff (PDF)

Transcription Factor Decoy (TFD) as a novel approach for the control of osteoclastic resorption

Progress in orthodontics, 2005, Vol.6 (2), p.238-247

2005

Volltextzugriff (PDF)

Leptin: regulatory role in bone metabolism and in inflammation

Reumatismo, 2002-07, Vol.54 (3), p.217

2002

Volltextzugriff (PDF)

Copernican revolution in the therapy of rheumatoid arthritis: the contribution of anti-TNFalpha drugs

Reumatismo, 2009-04, Vol.61 Suppl 1, p.1-23

2009

Volltextzugriff (PDF)

Disease activity assessment in large vessel vasculitis

Reumatismo, 2011-01, Vol.63 (2), p.86-90

2011

Volltextzugriff (PDF)

Biologic therapy with anti-TNFα in rheumathoid arthritis

Reumatismo, 2005, Vol.57 (4 Suppl), p.17-21

Ferraccioli, G

2005

Volltextzugriff (PDF)

Proteinuria: pathophysiology, diagnostic and therapeutic approach

Italian journal of medicine, 2013-04, Vol.3 (2), p.116-122

Valvo, Enrico

2013

Volltextzugriff (PDF)

Are there any positive effects of TNF-alpha blockers on bone metabolism?

Reumatismo, 2006-07, Vol.58 (3), p.199-205

2006

Volltextzugriff (PDF)

Modulation of estrogen receptor α levels by endogenous and exogenous ligands

Journal of biological research (Catanzaro), 2011-01, Vol.84 (1)

2011

Volltextzugriff (PDF)

Glucocorticoid-induced osteoporosis and rheumatic diseases. Pathogenesis, prevention and treatment

Reumatismo, 2006-01, Vol.58 (1), p.11-21

2006

Volltextzugriff (PDF)

Infections in patients with rheumatoid arthritis receiving anti-cytokine therapy: biological mechanisms and clinical aspects

Reumatismo, 2003-10, Vol.55 (4), p.224-235

2003

Volltextzugriff (PDF)

Gefitinib: a pharmacoeconomic profile of its use in patients with Non Small Cell Lung Cancer EGFR

Farmeconomia. Health economics and therapeutic pathways, 2011-06, Vol.12 (2), p.77-85

Sacchi, Viola

2011

Volltextzugriff (PDF)

Are there differences among anti-TNFα biological drugs?

Reumatismo, 2005, Vol.57 (4 Suppl), p.1-2

Valesini, G

2005

Volltextzugriff (PDF)

Role of Cell-Cell bond for the viability and the function of vascular smooth muscle cells

Journal of biological research (Catanzaro), 2010-01, Vol.83 (1)

2010

Volltextzugriff (PDF)

Safety of anti-TNFα biological drugs

Reumatismo, 2005, Vol.57 (4 Suppl), p.34-39

2005

Volltextzugriff (PDF)

Differences in pharmacology of tumor necrosis factor (TNF) antagonists

Reumatismo, 2005-01, Vol.57 (4 Suppl), p.8-16

2005

Volltextzugriff (PDF)

The laboratory approach in the diagnosis of systemic autoinflammatory diseases

Reumatismo, 2011-01, Vol.63 (2), p.101-110

2011

Volltextzugriff (PDF)

The role of rank-ligand inhibition in the treatment of postmenopausal osteoporosis

Reumatismo, 2011-06, Vol.62 (3), p.163-171

2011

Volltextzugriff (PDF)

Recurrent new-onset uveitis in a patient with rheumatoid arthritis during anti-TNFalpha treatment

Reumatismo, 2007-04, Vol.59 (2), p.169

2007

Volltextzugriff (PDF)

Hyper-IgD syndrome and other hereditary periodic fever syndromes

Reumatismo, 2004-07, Vol.56 (3), p.147

2004

Volltextzugriff (PDF)

Recommendations for the appropriate use of anti-TNFalpha therapy in patients with psoriatic arthritis. Italian Rheumatology Society

Reumatismo, 2004-07, Vol.56 (3), p.133-138

2004

Volltextzugriff (PDF)

The safety of interleukin-1 receptor antagonist (anakinra) in the treatment of rheumatoid arthritis

Reumatismo, 2004-01, Vol.56 (1 Suppl 1), p.74

Riente, L

2004

Volltextzugriff (PDF)

Biologic therapy with anti-TNFα in spondyloarthritides and other autoimmune diseases

Reumatismo, 2005, Vol.57 (4 Suppl), p.22-29

Lapadula, G

2005

Volltextzugriff (PDF)

Intra-articular treatment with the TNF-alpha antagonist, etanercept, in severe diffuse pigmented villonodular synovitis of the knee

Reumatismo, 2006-10, Vol.58 (4), p.268-274

2006

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Aktive Filter

SpracheDänisch

ThemaAged

KollektionIngentaConnect

SpracheItalienisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(55)

Sprache

Englisch
(16)

Erscheinungsjahr

n.n

Kollektion

Ingenta
(55)
IngentaConnect Journals
(51)
MEDLINE
(50)
EZB Electronic Journals Library
(48)
Springer Journals
(6)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(4)
Elsevier ScienceDirect Journals Complete
(2)
Wiley Online Library
(1)

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effect of β2 -adrenergic receptor gene Arg16Gly polymorphisms on response to long-acting β2-agonist in Chinese Han asthmatic patients

Glucocorticoid induced TNFR-related protein (GITR) as marker of human regulatory T cells: expansion of the GITR(+)CD25⁻ cell subset in patients with systemic lupus erythematosus

Transcription Factor Decoy (TFD) as a novel approach for the control of osteoclastic resorption

Leptin: regulatory role in bone metabolism and in inflammation

Copernican revolution in the therapy of rheumatoid arthritis: the contribution of anti-TNFalpha drugs

Disease activity assessment in large vessel vasculitis

Biologic therapy with anti-TNFα in rheumathoid arthritis

Proteinuria: pathophysiology, diagnostic and therapeutic approach

Are there any positive effects of TNF-alpha blockers on bone metabolism?

Modulation of estrogen receptor α levels by endogenous and exogenous ligands

Glucocorticoid-induced osteoporosis and rheumatic diseases. Pathogenesis, prevention and treatment

Infections in patients with rheumatoid arthritis receiving anti-cytokine therapy: biological mechanisms and clinical aspects

Gefitinib: a pharmacoeconomic profile of its use in patients with Non Small Cell Lung Cancer EGFR

Are there differences among anti-TNFα biological drugs?

Role of Cell-Cell bond for the viability and the function of vascular smooth muscle cells

Safety of anti-TNFα biological drugs

Differences in pharmacology of tumor necrosis factor (TNF) antagonists

The laboratory approach in the diagnosis of systemic autoinflammatory diseases

The role of rank-ligand inhibition in the treatment of postmenopausal osteoporosis

Recurrent new-onset uveitis in a patient with rheumatoid arthritis during anti-TNFalpha treatment

Hyper-IgD syndrome and other hereditary periodic fever syndromes

Recommendations for the appropriate use of anti-TNFalpha therapy in patients with psoriatic arthritis. Italian Rheumatology Society

The safety of interleukin-1 receptor antagonist (anakinra) in the treatment of rheumatoid arthritis

Biologic therapy with anti-TNFα in spondyloarthritides and other autoimmune diseases

Intra-articular treatment with the TNF-alpha antagonist, etanercept, in severe diffuse pigmented villonodular synovitis of the knee

Aktive Filter

Suchergebnisse filtern